药物治疗滴答和吉尔·德拉图雷特综合征
1Department of Clinical and Experimental Medicine, Child and Adolescent Neurology and Psychiatry, Catania University, Catania, Italy.
Handbook of clinical neurology
|February 3, 2026
概括
管理吉尔·德拉图雷特综合征 (GTS) 是复杂的. 多巴胺抗剂如阿里皮普拉是有效的,但其他药物和个性化方法对于最佳治疗至关重要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 吉尔·德拉图雷特综合征 (GTS) 带来了重大的临床挑战.
- GTS通常涉及诸如ADHD和强迫症等并发症,使治疗复杂化.
- 多学科的方法是管理GTS的标准.
研究的目的:
- 审查GTS中的药理学管理策略.
- 概述选择适当治疗剂的考虑因素.
- 突出基于证据和替代治疗选择.
主要方法:
- 审查目前的临床实践指南和GTS的药理选择.
- 分析支持不同类别药物的证据.
- 基于患者因素的个性化治疗选择的讨论.
主要成果:
- 多巴胺受体对抗剂,特别是非典型的抗精神病药物 (阿里皮普拉,瑞斯佩里),显示出最强有力的证据抑制滴滴.
- 阿尔法-2上腺激动剂,VMAT2抑制剂和托皮拉玛酸是有价值的辅助剂或替代品.
- 个性化治疗计划是必不可少的,考虑到症状严重程度和风险-益处概况.
结论:
- 药理管理GTS需要仔细考虑多种药物类别.
- 非典型的抗精神病药物是主要的药物,但其他药物具有重要的治疗作用.
- 针对个体患者需求量身定制治疗对于有效的GTS管理至关重要.
相关概念视频
Cholinergic Antagonists: Pharmacological Actions
1.7K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.7K
Nephrotic Syndrome I : Introduction
652
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
652
Acute Coronary Syndrome I: Introduction
1.0K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.0K
Drug Abuse and Addiction: Pharmacological Phenomena
1.3K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K
Irritable Bowel Syndrome I: Introduction
1.0K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.0K
Cardiopulmonary Resuscitation IV: Pharmacological Management
824
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
824


